Biosimilar developers are queueing up to file copycat versions of AbbVie's Humira, the world's best-selling drug, and now, another candidate has late…

Celltrion has new data in hand from a Phase III trial of its Rituxan biosimilar CT-P10, putting it in pole position to grab a piece of the brand's $7.39…

If Hilleman Labs is successful in scouting for a rotavirus vaccine partnership, India might see a new force added to its efforts to fight child and infant…

Sun Pharmaceutical Industries has taken the lead in a fiercely contested race to market with Johnson & Johnson for a new class of psoriasis drug.

Sun Pharma licensed a home-grown dengue fever vaccine that it hopes will rival Sanofi's Dengvaxia, which was recently delayed in India.

Complicated drug formulations are generally viewed as a barrier to generic competition, but that is not stopping India's Glenmark from placing Celgene…

With India in the throes of an outbreak of Chikungunya, local drugmaker Zydus Cadila has stepped up to develop a vaccine against the crippling viral disease--…

Japan's Otsuka is hoping that smart packaging could help one of its main pharma products maintain a hold in the marketplace.

R&D